0001209191-20-057052.txt : 20201104 0001209191-20-057052.hdr.sgml : 20201104 20201104201635 ACCESSION NUMBER: 0001209191-20-057052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200711 FILED AS OF DATE: 20201104 DATE AS OF CHANGE: 20201104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shah Jatin CENTRAL INDEX KEY: 0001782186 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 201288286 MAIL ADDRESS: STREET 1: C/O KARYOPHARM THERAPEUTICS, INC. STREET 2: 85 WELLS AVENUE CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-11 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001782186 Shah Jatin C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVE. NEWTON MA 02459 0 1 0 0 EVP, Chief Medical Officer Common Stock 2020-07-11 4 M 0 2413 A 43172 D Common Stock 2020-07-15 4 S 0 589 19.46 D 43229 D Restricted Stock Units 2020-07-11 4 M 0 2413 0.00 D Common Stock 2413 7237 D Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person. Includes 646 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2020. On July 11, 2019, the reporting person was granted 9,650 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. 25% of the restricted stock units vested on July 11, 2020. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date. /s/Christopher B. Primiano, Attorney-in-Fact for Jatin Shah 2020-11-04